S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
NASDAQ:RKDA

Arcadia Biosciences (RKDA) Stock Forecast, Price & News

$3.35
-0.09 (-2.62%)
(As of 09/29/2023 ET)
Compare
Today's Range
$3.30
$3.44
50-Day Range
$3.19
$5.21
52-Week Range
$3.10
$24.00
Volume
7,090 shs
Average Volume
30,671 shs
Market Capitalization
$3.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00

Arcadia Biosciences MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
347.8% Upside
$15.00 Price Target
Short Interest
Healthy
0.70% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.22mentions of Arcadia Biosciences in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$2,382 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($7.27) to ($3.92) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars


RKDA stock logo

About Arcadia Biosciences (NASDAQ:RKDA) Stock

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

RKDA Price History

RKDA Stock News Headlines

Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Q2 2023 Arcadia Biosciences Inc Earnings Call
Orion (OEC) Misses Q2 Earnings and Revenue Estimates
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
RKDA - Arcadia Biosciences, Inc.
8-K: Arcadia Biosciences, Inc.
Q1 2023 Arcadia Biosciences Inc Earnings Call
Arcadia Biosciences reports Q1 results
See More Headlines
Receive RKDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arcadia Biosciences and its competitors with MarketBeat's FREE daily newsletter.

RKDA Company Calendar

Last Earnings
8/10/2023
Today
10/01/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Agricultural production - crops
Sub-Industry
N/A
Current Symbol
NASDAQ:RKDA
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$15.00
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+347.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-15,380,000.00
Net Margins
-271.33%
Pretax Margin
-272.78%

Debt

Sales & Book Value

Annual Sales
$9.96 million
Book Value
$33.92 per share

Miscellaneous

Free Float
1,086,000
Market Cap
$3.72 million
Optionable
Not Optionable
Beta
0.98
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Stanley E. Jacot Jr. (Age 53)
    Pres, CEO & Director
    Comp: $527.9k
  • Ms. Laura Pitlik (Age 49)
    Chief Marketing Officer
    Comp: $374k
  • Mr. Thomas J. Schaefer (Age 47)
    CFO & Corp. Sec.
  • Ms. Belinda Yao
    VP of Operations
  • Mr. Brian Schaffer
    Sr. VP of Sales













RKDA Stock - Frequently Asked Questions

Should I buy or sell Arcadia Biosciences stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Arcadia Biosciences in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RKDA shares.
View RKDA analyst ratings
or view top-rated stocks.

What is Arcadia Biosciences' stock price forecast for 2023?

1 brokers have issued 12-month price targets for Arcadia Biosciences' shares. Their RKDA share price forecasts range from $10.00 to $20.00. On average, they predict the company's stock price to reach $15.00 in the next year. This suggests a possible upside of 347.8% from the stock's current price.
View analysts price targets for RKDA
or view top-rated stocks among Wall Street analysts.

How have RKDA shares performed in 2023?

Arcadia Biosciences' stock was trading at $0.2710 on January 1st, 2023. Since then, RKDA shares have increased by 1,136.2% and is now trading at $3.35.
View the best growth stocks for 2023 here
.

Are investors shorting Arcadia Biosciences?

Arcadia Biosciences saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 4,200 shares, an increase of 600.0% from the August 31st total of 600 shares. Based on an average daily volume of 36,900 shares, the short-interest ratio is presently 0.1 days. Approximately 0.7% of the shares of the stock are sold short.
View Arcadia Biosciences' Short Interest
.

When is Arcadia Biosciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our RKDA earnings forecast
.

How were Arcadia Biosciences' earnings last quarter?

Arcadia Biosciences, Inc. (NASDAQ:RKDA) released its quarterly earnings results on Thursday, August, 10th. The basic materials company reported ($2.64) EPS for the quarter, topping the consensus estimate of ($4.92) by $2.28. The basic materials company earned $1.39 million during the quarter, compared to analyst estimates of $1.43 million. Arcadia Biosciences had a negative trailing twelve-month return on equity of 69.76% and a negative net margin of 271.33%.

When did Arcadia Biosciences' stock split?

Shares of Arcadia Biosciences reverse split on the morning of Wednesday, January 24th 2018. The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 23rd 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What guidance has Arcadia Biosciences issued on next quarter's earnings?

Arcadia Biosciences issued an update on its second quarter 2023 earnings guidance on Thursday, July, 20th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.30 million-$1.50 million, compared to the consensus revenue estimate of $1.82 million.

What is Matthew Plavan's approval rating as Arcadia Biosciences' CEO?

1 employees have rated Arcadia Biosciences Chief Executive Officer Matthew Plavan on Glassdoor.com. Matthew Plavan has an approval rating of -100% among the company's employees. This puts Matthew Plavan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Arcadia Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcadia Biosciences investors own include Bionano Genomics (BNGO), ADMA Biologics (ADMA), Zosano Pharma (ZSAN), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), Organigram (OGI), Pennsylvania Real Estate Investment Trust (PEI), Novan (NOVN), CNBX Pharmaceuticals (CNBX) and Enerplus (ERF).

When did Arcadia Biosciences IPO?

(RKDA) raised $66 million in an initial public offering on Friday, May 15th 2015. The company issued 8,200,000 shares at a price of $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray served as the underwriters for the IPO.

What is Arcadia Biosciences' stock symbol?

Arcadia Biosciences trades on the NASDAQ under the ticker symbol "RKDA."

How do I buy shares of Arcadia Biosciences?

Shares of RKDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Arcadia Biosciences' stock price today?

One share of RKDA stock can currently be purchased for approximately $3.35.

How much money does Arcadia Biosciences make?

Arcadia Biosciences (NASDAQ:RKDA) has a market capitalization of $3.72 million and generates $9.96 million in revenue each year. The basic materials company earns $-15,380,000.00 in net income (profit) each year or ($21.36) on an earnings per share basis.

How can I contact Arcadia Biosciences?

Arcadia Biosciences' mailing address is 202 COUSTEAU PLACE SUITE 105, DAVIS CA, 85018. The official website for the company is www.arcadiabio.com. The basic materials company can be reached via phone at (530) 756-7077, via email at ir@arcadiabio.com, or via fax at 530-756-7027.

This page (NASDAQ:RKDA) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -